PTC Therapeutics | PTCT - Trade Creditors


PTC Therapeutics reported $45.49M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
BioCryst Pharmaceuticals USD 5.57M 3.02M Sep/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xencor USD 9.08M 9.45M Sep/2025